However, there is growing evidence that elevated circulating insulin and insulin-related peptides and abnormal insulin response to glucose can be identified already in drug-naïve first-episode patients [29-32], suggesting that insulin signaling is impaired in schizophrenia [30,31]. Here, INS is linked to schizophrenia.